nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0301	0.0304	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Other—GNRHR—adrenal gland cancer	0.0298	0.0301	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0295	0.0298	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0286	0.0289	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0238	0.0241	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0213	0.0215	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0201	0.0203	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0201	0.0203	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0199	0.0201	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0168	0.0169	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0167	0.0169	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0158	0.0159	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.015	0.0152	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.015	0.0151	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0143	0.0144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.013	0.0132	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0128	0.0129	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—GNRHR—adrenal gland cancer	0.012	0.0121	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0111	0.0112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0111	0.0112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.011	0.0111	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.011	0.0111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.0106	0.0107	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.0102	0.0103	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0101	0.0102	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.01	0.0101	CbGpPWpGaD
Methylscopolamine bromide—Scopolamine—ABCB1—adrenal gland cancer	0.00986	1	CrCbGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00945	0.00955	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00929	0.00938	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00899	0.00908	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00896	0.00905	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00888	0.00896	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00846	0.00855	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00843	0.00852	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00843	0.00851	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00835	0.00844	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00831	0.00839	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00771	0.00779	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00769	0.00776	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00761	0.00769	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00734	0.00741	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0072	0.00727	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00689	0.00696	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00679	0.00686	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00666	0.00672	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00664	0.0067	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00657	0.00664	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00654	0.00661	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00652	0.00658	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00646	0.00652	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.00642	0.00648	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00625	0.00631	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00623	0.00629	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00617	0.00623	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00617	0.00623	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00593	0.00599	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00591	0.00597	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0059	0.00596	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00586	0.00591	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00507	0.00512	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00505	0.0051	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.005	0.00505	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00478	0.00483	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00477	0.00481	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00472	0.00477	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00452	0.00456	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.0045	0.00455	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00446	0.0045	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00434	0.00439	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00433	0.00437	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00429	0.00433	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00428	0.00433	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00416	0.0042	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00414	0.00418	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0041	0.00414	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00407	0.00411	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00373	0.00377	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00369	0.00373	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00364	0.00368	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00363	0.00366	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00339	0.00342	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00338	0.00341	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00334	0.00338	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0033	0.00333	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00329	0.00333	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00318	0.00322	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00288	0.00291	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00286	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00286	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00286	0.00288	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00283	0.00286	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00263	0.00265	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00262	0.00265	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0026	0.00263	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00259	0.00262	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00259	0.00262	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00257	0.00259	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00257	0.00259	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00256	0.00258	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00255	0.00258	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00255	0.00257	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00253	0.00256	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00252	0.00255	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00252	0.00255	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00251	0.00254	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00238	0.00241	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00238	0.0024	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00238	0.0024	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00237	0.0024	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00236	0.00239	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00235	0.00238	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00235	0.00237	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00232	0.00235	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00232	0.00234	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00232	0.00234	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00231	0.00233	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00229	0.00232	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00229	0.00231	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00224	0.00226	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00223	0.00226	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00221	0.00224	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00221	0.00223	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00218	0.0022	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00215	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00215	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00211	0.00213	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.002	0.00202	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.002	0.00202	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00195	0.00196	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00192	0.00193	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00183	0.00185	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00177	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00177	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00177	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00176	0.00178	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00175	0.00176	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00166	0.00168	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00166	0.00168	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00164	0.00166	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00161	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.00157	0.00159	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00155	0.00157	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00155	0.00156	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00154	0.00155	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00153	0.00155	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00153	0.00155	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00152	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00149	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00148	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00147	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.00142	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00141	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.00141	0.00142	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00141	0.00142	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.0014	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.0014	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00139	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00139	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00137	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.00137	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00135	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00135	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00134	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00133	0.00134	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.00129	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.00129	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.00128	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.00127	0.00128	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.00118	0.0012	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.00117	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.00114	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.00113	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.0011	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.001	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000997	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000987	0.000997	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000983	0.000993	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00098	0.00099	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00097	0.00098	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.00095	0.000959	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.00095	0.000959	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000932	0.000941	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000908	0.000917	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000905	0.000914	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000896	0.000905	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000834	0.000842	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000831	0.000839	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000826	0.000835	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000823	0.000831	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000804	0.000812	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000801	0.000809	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000797	0.000805	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000794	0.000802	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000793	0.000801	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000786	0.000794	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000777	0.000785	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000775	0.000782	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000767	0.000775	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000762	0.000769	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000752	0.00076	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000729	0.000736	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000669	0.000676	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000667	0.000673	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.00066	0.000667	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000639	0.000646	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000582	0.000588	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.00058	0.000586	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000574	0.00058	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000544	0.000549	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000536	0.000542	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000535	0.00054	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.00053	0.000535	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.00053	0.000535	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000528	0.000533	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000523	0.000528	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000513	0.000519	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000512	0.000517	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.00051	0.000515	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000507	0.000512	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000431	0.000435	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000383	0.000387	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000382	0.000385	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000378	0.000382	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000362	0.000365	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000303	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000302	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000299	0.000302	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000255	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000254	0.000256	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000251	0.000254	CbGpPWpGaD
